Aztreonam

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5176 publications

An update on beta-lactam-beta-lactamase inhibitor combinations for the treatment of carbapenem-resistant gram-negative pathogens.

An update on beta-lactam-beta-lactamase inhibitor combinations for the treatment of carbapenem-resistant gram-negative pathogens.

Journal: Expert opinion on drug metabolism & toxicology

Published: June 19, 2026

Phase I dose-ascending, safety, and pharmacokinetics study of APC148, a novel metallo-β-lactamase inhibitor, in healthy volunteers.

Phase I dose-ascending, safety, and pharmacokinetics study of APC148, a novel metallo-β-lactamase inhibitor, in healthy volunteers.

Journal: Antimicrobial agents and chemotherapy

Published: June 17, 2026

Evaluation of drug-drug interaction between nacubactam and β-lactam antibiotic (cefepime, aztreonam, meropenem, or piperacillin) in Japanese healthy participants.

Evaluation of drug-drug interaction between nacubactam and β-lactam antibiotic (cefepime, aztreonam, meropenem, or piperacillin) in Japanese healthy participants.

Journal: Antimicrobial agents and chemotherapy

Published: June 09, 2026

Evaluation of in vitro synergy of cefepime/enmetazobactam combined with aztreonam against metallo-β-lactamase-producing Enterobacterales.

Evaluation of in vitro synergy of cefepime/enmetazobactam combined with aztreonam against metallo-β-lactamase-producing Enterobacterales.

Journal: The Journal of antimicrobial chemotherapy

Published: June 08, 2026

Interpreting ceftazidime-avibactam plus aztreonam synergy testing in the era of aztreonam-avibactam.

Interpreting ceftazidime-avibactam plus aztreonam synergy testing in the era of aztreonam-avibactam.

Journal: Indian journal of medical microbiology

Published: June 03, 2026

Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in Pseudomonas aeruginosa.

Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in Pseudomonas aeruginosa.

Journal: Antimicrobial agents and chemotherapy

Published: May 29, 2026

Comparative activity of ceftibuten combinations with avibactam, ledaborbactam, and xeruborbactam against recombinant β-lactamase-producing Escherichia coli and contemporary WGS-characterized strains of carbapenemase-producing Enterobacterales.

Comparative activity of ceftibuten combinations with avibactam, ledaborbactam, and xeruborbactam against recombinant β-lactamase-producing Escherichia coli and contemporary WGS-characterized strains of carbapenemase-producing Enterobacterales.

Journal: Antimicrobial agents and chemotherapy

Published: May 29, 2026

A multifunctional nanobooster to restore ceftazidime susceptibility in mucoid Pseudomonas aeruginosa.

A multifunctional nanobooster to restore ceftazidime susceptibility in mucoid Pseudomonas aeruginosa.

Journal: Materials horizons

Published: May 27, 2026

Therapeutic strategies for multi-resistant Escherichia coli in urinary tract infections-a cause for concern.

Therapeutic strategies for multi-resistant Escherichia coli in urinary tract infections-a cause for concern.

Journal: JAC-antimicrobial resistance

Published: May 25, 2026

Comparison of laboratory-developed methods for aztreonam plus ceftazidime-avibactam antimicrobial susceptibility testing for metallo-beta-lactamase-producing Enterobacterales.

Comparison of laboratory-developed methods for aztreonam plus ceftazidime-avibactam antimicrobial susceptibility testing for metallo-beta-lactamase-producing Enterobacterales.

Journal: Journal of clinical microbiology

Published: May 22, 2026

A Divergent MBL-Fold Metallo-Hydrolase (Kmh-1) from Klebsiella pneumoniae Confers Aztreonam Degradation and Expands the β-Lactamase Landscape.

A Divergent MBL-Fold Metallo-Hydrolase (Kmh-1) from Klebsiella pneumoniae Confers Aztreonam Degradation and Expands the β-Lactamase Landscape.

Journal: ACS infectious diseases

Published: May 19, 2026

Treatment of Post-Neurosurgical Ventriculitis and Scalp Infection Caused by Klebsiella pneumoniae Carbapenemase and New Delhi Metallo-β-Lactamase Co-Producing Carbapenem-Resistant Klebsiella pneumoniae: A Case Report.

Treatment of Post-Neurosurgical Ventriculitis and Scalp Infection Caused by Klebsiella pneumoniae Carbapenemase and New Delhi Metallo-β-Lactamase Co-Producing Carbapenem-Resistant Klebsiella pneumoniae: A Case Report.

Journal: Cureus

Published: May 15, 2026

Showing 1-12 of 5,176

Last Updated: 06/30/2026